PYXS
Pyxis OncologyFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
Current thesis
Positive topline plus at least one partnership or non-dilutive deal that meaningfully de-risks the pipeline and triggers multiple expansion among small-cap oncology peers. Valuation rationale: Bull = $4.60 is set as ~4.0x the ANCHOR and is expected over ~12 months if a positive Phase 1 topline (primary short catalyst) is followed by a BD deal/IND advancement (long catalyst); small-cap oncology precedents show 3–5x re-ratings on this sequence [#PR-2025-09-12][#10Kp5].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Binary clinical readouts (high upside or catastrophic downside)
Momentum
4
Value
41
Sentiment
46
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.15 · Bull $4.60 · Bear $0.29
Data freshness
Prices
As of 2026-06-11
Fundamentals
As of 2026-06-09 • Vendor: Data Vendor v1
Scores
As of 2026-06-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-01 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-11
Investment thesis
As of 2026-06-11
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $6.93
Why
Momentum4 · Δ7d -
Value41 · Δ7d -0.1
Sentiment46 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
4
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.1
Sentiment
46
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 3.5 / Value 41.0 / Sentiment 46.1
Fundamentals (TTM)As of 2026-06-09
Fundamentals (TTM)
As of 2026-06-09
Market Cap
$107.7M
Beta
1.45
Shares Out
62.26M
P/E (TTM) · Derived
-1.8
P/S (TTM)
26.72
P/FCF (TTM) · Derived
-1.47
Rev YoY
-100.0%
EPS YoY
-0.7%
Gross Margin
0.0%
Op Margin
-3765.7%
Net Debt
-$126.83M
Current Ratio
4.29
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology